Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 18Thoracic 13Gastrointestinal 12Genitourinary 9Lymphoid 5Head & Neck 5Gynecologic 5Other hematologic neoplasm 4Other solid neoplasm 3Plasma cell 2Endocrine 2Classical hematology 2Dermatologic 1

Conditions

Thrombocytopenia 1Anemia 1

Interventions

Epoetin Alfa 27Darbepoetin alfa 13Cytarabine 9Dalteparin 8Rivaroxaban 7Daunorubicin 7apixaban 6Etoposide 6Methotrexate 5Idarubicin 5Heparin, Low-Molecular-Weight 5Cyclophosphamide 5emicizumab 4Tinzaparin 4Thioguanine 4Mitoxantrone 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Enoxaparin 4pegfilgrastim 3hetrombopag 3epoetin beta 3Saline Solution 3Radiotherapy 3Hydrocortisone 3Erythropoietin 3Dexamethasone 3Aspirin 3Asparaginase 3telapristone acetate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Injections × Classical hematology × Clear all
NCT01663441 2020-09-16

A Phase â…¢a Study of Genetically Modified Recombinant Human Interleukin-11

Beijing Northland Biotech. Co., Ltd.

Phase 3 Completed
62 enrolled
Classical hematology

Thrombocytopenia

NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Sandoz

Phase 3 Completed
114 enrolled 10 charts
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡